Developer docs
API playgroundTry for free, no card

Search company profiles

Haier Biomedical

Full company profile

uuid000bx2s

Namestring
Haier Biomedical
Legal namestring
Haier Biomedical UK Limited
Company typeenum
Private
Founded yearint
2016
Short descriptiontext

Haier Biomedical manufactures IoT-enabled cold chain equipment spanning -196°C to +8°C, serving hospitals, biobanks, universities, and government health programs across 140+ countries via direct sales and tenders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSunbury, United Kingdom
HQ citystring
Sunbury
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cold chain equipment, ultra-low temperature freezers, blood bank refrigerators, vaccine cold storage, IoT laboratory monitoring
Industry5 codes
1Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
CodeHLAAAJANPrimaryYes
2Cold Chain & Temperature-Controlled Storage Equipment
CodeIMAHAKAJPrimaryNo
3Cold Chain Monitoring, Sensors & Control Towers (IoT, data loggers)
CodeHLAGAMAGPrimaryNo
4Vaccine Cold Chain, Storage & Distribution
CodeHLAIAEAKPrimaryNo
5Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
CodeHLAGAIAJPrimaryNo
NAICS code2 codes
  • Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing333415
  • Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use334512
SIC code3 codes
  • Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip3585
  • Refrigeration & Service Industry Machinery3580
  • Laboratory Apparatus & Furniture3821
Product category
Medical Cold Chain Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Cold Chain Equipment Sales
TypeHardware Sales
Description

Primary revenue stream from manufacturing and selling temperature-controlled storage equipment including ULT freezers, cryo freezers, biomedical refrigerators, blood bank refrigerators, pharmacy refrigerators, laboratory refrigerators, and liquid nitrogen storage solutions. Products sold as one-time capital purchases with various temperature specifications (-196°C to +8°C range).

haierbiomedical.co.uk
2Laboratory Equipment Sales
TypeHardware Sales
Description

Sales of complementary laboratory equipment including centrifuges, autoclaves, biological safety cabinets, clean benches, CO2 incubators, standard incubators, drying ovens, fume hoods, and freeze dryers.

haierbiomedical.co.uk
3Service and Maintenance
TypeProfessional Services
Description

Service revenue from maintenance contracts, breakdown services, calibration and temperature mapping, IQ/OQ/PQ qualification services, and monitoring service contracts for installed equipment.

haierbiomedical.co.uk
4Consumables
TypeHardware Sales
Description

Sales of consumable products including PCR series, centrifuge tubes, cell culture products, frozen racks, pipette tips, and cryogenic accessories.

haierbiomedical.co.uk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B enterprise pricing - product-specific quotes
ModelOtherBilling cadencePay-as-you-go
Notes

Contact sales for product pricing. Individual product configurations and bulk orders require custom quotes. Payment terms: 30 days from delivery.

haierbiomedical.co.uk
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Haier Biomedical manufactures and supplies a complete cold chain solution for life sciences, covering temperatures from -196°C to +8°C, with ultra-low temperature freezers, cryo freezers, biomedical/laboratory/pharmacy/blood bank refrigerators, liquid nitrogen storage solutions, and vaccine refrigerators. The portfolio is complemented by laboratory equipment (CO2 incubators, biological safety cabinets, centrifuges, autoclaves, freeze dryers, fume hoods) and integrated with the proprietary IoT Cloud Platform and five U-Network solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) for real-time monitoring and intelligent management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 764 vaccine refrigerators delivered to Uzbekistan through UNICEF tender
+4 more records
Product overview1 text field

Haier Biomedical is a comprehensive cold chain solution provider and manufacturer offering laboratory and biomedical equipment across temperature ranges from -196°C to +8°C. The product portfolio consists of multiple core product lines including ultra-low temperature (ULT) freezers, cryogenic storage systems, biomedical freezers, laboratory refrigerators, pharmacy refrigerators, blood bank refrigerators, and liquid nitrogen storage solutions. These are complemented by laboratory equipment such as CO₂ incubators, biological safety cabinets, centrifuges, autoclaves, freeze dryers, and fume hoods. The company also provides specialized vaccine storage solutions including solar-powered refrigerators for off-grid applications, ice-lined refrigerators, and transport coolers. Central to the offering is the IoT-based solution platform comprising five interconnected networks: U-Biobank, U-Vaccine, U-Reagent, U-Blood, and U-Laboratory, which enable cloud-based monitoring and management of connected equipment. Additional offerings include consumables (PCR series, centrifuge tubes, cell culture supplies), wireless monitoring systems, and the Forlife sub-brand for preservation solutions. The portfolio supports the full cold chain from sample collection through storage to transportation.

Product and service35 records
1Cryo Freezer
CategoryCold Storage Equipment
2ULT Freezer (Ultra Low Temperature Freezer)
CategoryCold Storage Equipment
3Biomedical Freezer
CategoryCold Storage Equipment
4Laboratory Refrigerator
CategoryCold Storage Equipment
5Pharmacy Refrigerator
CategoryCold Storage Equipment
6Blood Bank Refrigerator
CategoryCold Storage Equipment
7Liquid Nitrogen Storage Solutions
CategoryCold Storage Equipment
8Vaccine Refrigerator/Freezer
CategoryCold Storage Equipment
9Solar Direct Drive Refrigerators
CategoryCold Storage Equipment
10Ice-Lined Refrigerator
CategoryCold Storage Equipment
11RFID Pharmacy Refrigerator
CategoryCold Storage Equipment
12Automated Blood Management Refrigerator
CategoryCold Storage Equipment
13Spark Free Refrigerator/Freezer
CategoryCold Storage Equipment
14Self-Pressurised Liquid Nitrogen Supply Vessels
CategoryCold Storage Equipment
15Transport Cooler
CategoryCold Chain Logistics
16CO2 Incubator
CategoryLaboratory Equipment
17Biological Safety Cabinet
CategoryLaboratory Equipment
18Centrifuge
CategoryLaboratory Equipment
19Autoclave
CategoryLaboratory Equipment
20Freeze Dryer
CategoryLaboratory Equipment
21Clean Bench & Laminar Flow
CategoryLaboratory Equipment
22Fume Hood
CategoryLaboratory Equipment
23Climate Chamber
CategoryLaboratory Equipment
24Standard Incubator
CategoryLaboratory Equipment
25Drying Oven
CategoryLaboratory Equipment
26Plasma Apheresis System
CategoryBlood Banking Equipment
27Remote Temperature Monitoring Device
CategoryMonitoring Solutions
28Wireless Monitoring System
CategoryMonitoring Solutions
29U-Biobank Network Solution
CategoryIoT Solution Platform
30U-Vaccine Network Solution
CategoryIoT Solution Platform
31U-Reagent Network Solution
CategoryIoT Solution Platform
32U-Blood Network Solution
CategoryIoT Solution Platform
33U-Laboratory Network Solution
CategoryIoT Solution Platform
34Laboratory Consumables
CategoryConsumables
35Maintenance and Calibration Services
CategoryProfessional Services
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-01-01
Description

Haier Biomedical won the UNICEF CCEOP (Coordination Centre for Essential Equipment and Other Supplies) immunization tender in Uzbekistan in 2019, supplying 764 vaccine refrigerators. This represents a core government partnership for vaccine cold chain infrastructure.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

WHO collaboration in Cameroon where Haier Biomedical supplied 196 units of blood refrigerators and plasma freezers to help build the national blood transfusion centre and 4 regional blood transfusion centres, funded by WHO and ISDB Bank.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French manufacturer of ultra-low temperature freezers, laboratory freezers, and cryogenic storage equipment. Comparable product offering to Haier's ULT and cryo freezer lines, with strong European research-customer footprint similar to Haier Biomedical UK.

TypeDirect peer
Description

US-based manufacturer of medical-grade cold storage including blood bank refrigerators, plasma freezers, and pharmacy/vaccine storage. Direct overlap with Haier's blood bank and pharmacy refrigerator portfolio serving hospitals and transfusion centres.

TypeDirect peer
Description

Danish manufacturer specializing in ULT freezers, laboratory refrigerators, and cryogenic storage. Comparable in product range to Haier's biomedical freezers and ULT lines, often competing on technical specifications and energy efficiency.

TypeDirect peer
Description

Luxembourg-based specialist in vaccine cold chain and blood bank refrigeration, particularly strong in WHO/UNICEF tenders and solar direct drive units for emerging markets. Direct competitor for the same government tender customers that drive Haier's largest wins.

TypeEmerging player
Description

US manufacturer of laboratory equipment including biological safety cabinets, fume hoods, freeze dryers, and incubators — categories overlapping with Haier's laboratory infrastructure portfolio (U-Laboratory solutions).

TypeBroad incumbent
Description

After acquiring the legacy Cantel/MiniTegra cold chain business and broader sterilization equipment portfolio, Steris serves healthcare and life sciences customers with adjacent cold storage, washers, and sterilization equipment comparable to Haier's lab infrastructure offering.

TypeBroad incumbent
Description

Global life sciences tools leader offering ultra-low temperature freezers, cold storage, and connected monitoring solutions through its Laboratory Products and Services segment. Directly competes in the ULT and biomedical freezer categories, with broader portfolio scale and deeper research-customer relationships.

TypeDirect peer
Description

German life science tools company with a strong cryo and ULT freezer portfolio (CryoCube, Innova, Eppendorf CryoStorage) plus laboratory equipment. Overlaps with Haier's ULT freezers, cryogenic storage, and consumables offerings for research and biobank customers.

TypeDirect peer
Description

Manufacturer of biomedical and pharmaceutical cold chain equipment including the well-known PHCbi brand ULT freezers, pharmacy refrigerators, and blood bank refrigerators. Direct head-to-head competitor across the -80°C to +8°C temperature range.

10ZSCWD (Zhongshanshi'an Bio-medical)
TypeRegional player
Description

Chinese biomedical cold chain manufacturer with strong regional presence in domestic healthcare and government tenders. Competes with Haier Biomedical primarily within China and select Asian markets, with overlap in blood bank, vaccine, and pharmacy refrigerators.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Haier Biomedical

Medical Cold Chain Equipmenthaierbiomedical.co.uk

Haier Biomedical manufactures IoT-enabled cold chain equipment spanning -196°C to +8°C, serving hospitals, biobanks, universities, and government health programs across 140+ countries via direct sales and tenders.

Haier Biomedical firmographics

Firmographics
Name
Haier Biomedical
Legal name
Haier Biomedical UK Limited
Website
https://haierbiomedical.co.uk
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
251–500 employees
Short description
Haier Biomedical manufactures IoT-enabled cold chain equipment spanning -196°C to +8°C, serving hospitals, biobanks, universities, and government health programs across 140+ countries via direct sales and tenders.
Ownership category
akta.pro rank

Haier Biomedical industry classification

Industry
Product category
Medical Cold Chain Equipment
NAICS
Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing (333415), Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use (334512)
SIC
Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip (3585), Refrigeration & Service Industry Machinery (3580), Laboratory Apparatus & Furniture (3821)
akta.pro primary industry
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)
akta.pro secondary industries
Cold Chain & Temperature-Controlled Storage Equipment (IMAHAKAJ), Cold Chain Monitoring, Sensors & Control Towers (IoT, data loggers) (HLAGAMAG), Vaccine Cold Chain, Storage & Distribution (HLAIAEAK), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)

Keywords

  • Cold chain equipment
  • Ultra-low temperature freezers
  • Blood bank refrigerators
  • Vaccine cold storage
  • IoT laboratory monitoring

Where Haier Biomedical is headquartered

Location

Headquarters

HQ city
Sunbury
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Haier Biomedical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Cold Chain Equipment Sales: Primary revenue stream from manufacturing and selling temperature-controlled storage equipment including ULT freezers, cryo freezers, biomedical refrigerators, blood bank refrigerators, pharmacy refrigerators, laboratory refrigerators, and liquid nitrogen storage solutions. Products sold as one-time capital purchases with various temperature specifications (-196°C to +8°C range).
  2. Laboratory Equipment Sales: Sales of complementary laboratory equipment including centrifuges, autoclaves, biological safety cabinets, clean benches, CO2 incubators, standard incubators, drying ovens, fume hoods, and freeze dryers.
  3. Service and Maintenance: Service revenue from maintenance contracts, breakdown services, calibration and temperature mapping, IQ/OQ/PQ qualification services, and monitoring service contracts for installed equipment.
  4. Consumables: Sales of consumable products including PCR series, centrifuge tubes, cell culture products, frozen racks, pipette tips, and cryogenic accessories.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goB2B enterprise pricing - product-specific quotes

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Haier Biomedical product offering

Product offering

Core offering

Haier Biomedical manufactures and supplies a complete cold chain solution for life sciences, covering temperatures from -196°C to +8°C, with ultra-low temperature freezers, cryo freezers, biomedical/laboratory/pharmacy/blood bank refrigerators, liquid nitrogen storage solutions, and vaccine refrigerators. The portfolio is complemented by laboratory equipment (CO2 incubators, biological safety cabinets, centrifuges, autoclaves, freeze dryers, fume hoods) and integrated with the proprietary IoT Cloud Platform and five U-Network solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) for real-time monitoring and intelligent management.

Product overview

Haier Biomedical is a comprehensive cold chain solution provider and manufacturer offering laboratory and biomedical equipment across temperature ranges from -196°C to +8°C. The product portfolio consists of multiple core product lines including ultra-low temperature (ULT) freezers, cryogenic storage systems, biomedical freezers, laboratory refrigerators, pharmacy refrigerators, blood bank refrigerators, and liquid nitrogen storage solutions. These are complemented by laboratory equipment such as CO₂ incubators, biological safety cabinets, centrifuges, autoclaves, freeze dryers, and fume hoods. The company also provides specialized vaccine storage solutions including solar-powered refrigerators for off-grid applications, ice-lined refrigerators, and transport coolers. Central to the offering is the IoT-based solution platform comprising five interconnected networks: U-Biobank, U-Vaccine, U-Reagent, U-Blood, and U-Laboratory, which enable cloud-based monitoring and management of connected equipment. Additional offerings include consumables (PCR series, centrifuge tubes, cell culture supplies), wireless monitoring systems, and the Forlife sub-brand for preservation solutions. The portfolio supports the full cold chain from sample collection through storage to transportation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cryo Freezer
  • ULT Freezer (Ultra Low Temperature Freezer)
  • Biomedical Freezer
  • Laboratory Refrigerator
  • Pharmacy Refrigerator
  • Blood Bank Refrigerator
  • Liquid Nitrogen Storage Solutions
  • Vaccine Refrigerator/Freezer
  • Solar Direct Drive Refrigerators
  • Ice-Lined Refrigerator
  • RFID Pharmacy Refrigerator
  • Automated Blood Management Refrigerator
  • Spark Free Refrigerator/Freezer
  • Self-Pressurised Liquid Nitrogen Supply Vessels
  • Transport Cooler
  • CO2 Incubator
  • Biological Safety Cabinet
  • Centrifuge
  • Autoclave
  • Freeze Dryer
  • Clean Bench & Laminar Flow
  • Fume Hood
  • Climate Chamber
  • Standard Incubator
  • Drying Oven
  • Plasma Apheresis System
  • Remote Temperature Monitoring Device
  • Wireless Monitoring System
  • U-Biobank Network Solution
  • U-Vaccine Network Solution
  • U-Reagent Network Solution
  • U-Blood Network Solution
  • U-Laboratory Network Solution
  • Laboratory Consumables
  • Maintenance and Calibration Services

Quantifiable outcome

  • 764 vaccine refrigerators delivered to Uzbekistan through UNICEF tender
  • +4 more outcomes

Companies that use Haier Biomedical

Customer profile

Named customers18 records

Segments5 records

Ideal customer profiles3 records

Haier Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Haier Biomedical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • UNICEF/CCEOPcoreChannel Partner/ Reseller/ Distributor · 1 January 2019Haier Biomedical won the UNICEF CCEOP (Coordination Centre for Essential Equipment and Other Supplies) immunization tender in Uzbekistan in 2019, supplying 764 vaccine refrigerators. This represents a core government partnership for vaccine cold chain infrastructure.
  • World Health Organization (WHO)coreChannel Partner/ Reseller/ DistributorWHO collaboration in Cameroon where Haier Biomedical supplied 196 units of blood refrigerators and plasma freezers to help build the national blood transfusion centre and 4 regional blood transfusion centres, funded by WHO and ISDB Bank.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Haier Biomedical competitors and assessment

Company assessment

Direct peers

  • Froilabo: French manufacturer of ultra-low temperature freezers, laboratory freezers, and cryogenic storage equipment. Comparable product offering to Haier's ULT and cryo freezer lines, with strong European research-customer footprint similar to Haier Biomedical UK.
  • Helmer Scientific: US-based manufacturer of medical-grade cold storage including blood bank refrigerators, plasma freezers, and pharmacy/vaccine storage. Direct overlap with Haier's blood bank and pharmacy refrigerator portfolio serving hospitals and transfusion centres.
  • Arctiko: Danish manufacturer specializing in ULT freezers, laboratory refrigerators, and cryogenic storage. Comparable in product range to Haier's biomedical freezers and ULT lines, often competing on technical specifications and energy efficiency.
  • B Medical Systems: Luxembourg-based specialist in vaccine cold chain and blood bank refrigeration, particularly strong in WHO/UNICEF tenders and solar direct drive units for emerging markets. Direct competitor for the same government tender customers that drive Haier's largest wins.
  • Eppendorf: German life science tools company with a strong cryo and ULT freezer portfolio (CryoCube, Innova, Eppendorf CryoStorage) plus laboratory equipment. Overlaps with Haier's ULT freezers, cryogenic storage, and consumables offerings for research and biobank customers.
  • PHC Holdings (formerly Panasonic Healthcare): Manufacturer of biomedical and pharmaceutical cold chain equipment including the well-known PHCbi brand ULT freezers, pharmacy refrigerators, and blood bank refrigerators. Direct head-to-head competitor across the -80°C to +8°C temperature range.

Emerging players

  • Labconco: US manufacturer of laboratory equipment including biological safety cabinets, fume hoods, freeze dryers, and incubators — categories overlapping with Haier's laboratory infrastructure portfolio (U-Laboratory solutions).

Broad incumbents

  • Steris Life Sciences: After acquiring the legacy Cantel/MiniTegra cold chain business and broader sterilization equipment portfolio, Steris serves healthcare and life sciences customers with adjacent cold storage, washers, and sterilization equipment comparable to Haier's lab infrastructure offering.
  • Thermo Fisher Scientific: Global life sciences tools leader offering ultra-low temperature freezers, cold storage, and connected monitoring solutions through its Laboratory Products and Services segment. Directly competes in the ULT and biomedical freezer categories, with broader portfolio scale and deeper research-customer relationships.

Regional players

  • ZSCWD (Zhongshanshi'an Bio-medical): Chinese biomedical cold chain manufacturer with strong regional presence in domestic healthcare and government tenders. Competes with Haier Biomedical primarily within China and select Asian markets, with overlap in blood bank, vaccine, and pharmacy refrigerators.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Haier Biomedical social profiles

Digital presence

Haier Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Haier Biomedical leadership team

Management profile

Number of profiles

Profiles1 record

Haier Biomedical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Haier Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haier Biomedical

What does Haier Biomedical do?

Haier Biomedical manufactures and supplies a complete cold chain solution for life sciences, covering temperatures from -196°C to +8°C, with ultra-low temperature freezers, cryo freezers, biomedical/laboratory/pharmacy/blood bank refrigerators, liquid nitrogen storage solutions, and vaccine refrigerators. The portfolio is complemented by laboratory equipment (CO2 incubators, biological safety cabinets, centrifuges, autoclaves, freeze dryers, fume hoods) and integrated with the proprietary IoT Cloud Platform and five U-Network solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) for real-time monitoring and intelligent management.

Is Haier Biomedical a public or private company?

Haier Biomedical is a private company. It is classified as corporate owned and is currently operating.

When was Haier Biomedical founded?

Haier Biomedical was founded in 2016. It employs 251 to 500 people.

Where is Haier Biomedical based?

Haier Biomedical is headquartered in Sunbury, United Kingdom, in the Europe region.

How does Haier Biomedical make money?

Four revenue lines are on record. Cold Chain Equipment Sales are the primary driver. The others are laboratory Equipment Sales, service and Maintenance and consumables.

Who are Haier Biomedical's main competitors?

Direct peers on record are Froilabo, Helmer Scientific, Arctiko, B Medical Systems, Eppendorf and PHC Holdings (formerly Panasonic Healthcare). Labconco is listed as an emerging player. Broad incumbents are Steris Life Sciences and Thermo Fisher Scientific. ZSCWD (Zhongshanshi'an Bio-medical) is listed as a regional player.

Does Haier Biomedical have an API?

No public API is recorded for Haier Biomedical.

What industry is Haier Biomedical in?

Haier Biomedical's product category is Medical Cold Chain Equipment. Its primary akta.pro industry code is HLAAAJAN, Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies, with a secondary code of IMAHAKAJ, Cold Chain & Temperature-Controlled Storage Equipment. Its NAICS code is 333415 and its SIC code is 3585.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerHaier Biomedical Saves Lives by Moving the Blood Bank Right Beside the PatientHaier Biomedical has launched the U-Blood platform ecosystem, a decentralized blood management solution using RFID IoT technology that moves smart blood refrigerators directly to operating rooms, wards, and ambulances for instant blood access and end-to-end traceability. The system has been deployed at Johns Hopkins Hospital in the US and at Chinese hospitals including the Affiliated Hospital of Qingdao University and the PLA General Hospital (301 Hospital) in Beijing, enabling blood delivery within one minute during surgery and reducing unnecessary blood usage through AI-driven personalized programs. The company has transformed from a cold chain brand into an IoT-ready biotechnology platform ecosystem connecting hospitals, blood centers, and governments, with plans to expand into a broader 5U platform covering blood, biobank, vaccine, reagent, and stem cell solutions.GurufocusHaier Biomedical Debuts Innovative Automated Low-Carbon Cold StoHaier Biomedical showcased products at Europe Biobank Week 2026 in Prague and Interphex Week Tokyo 2026, launching the HAB80-60KA/60KB automated ultra-low temperature sample storage system for European biobanks and the DWL368BPST ultra-low temperature freezer designed for space-constrained Japanese laboratories. The company is positioning its transition from product export to ecosystem integration through localized R&D and deep-rooted local service capabilities. The launches feature low-carbon design, AI-driven automated monitoring, and modular scalability targeting biobank and laboratory upgrade needs in both markets.Third NewsHaier Biomedical Launches Innovative Cold Storage Solutions at Major Global Trade FairsHaier Biomedical showcased its latest low-carbon, automated cold storage solutions at Europe Biobank Week 2026 in Prague and Interphex Week Tokyo 2026, unveiling products tailored for specific regional markets. The company launched the HAB80-60KA/KB automated ultra-low temperature storage system capable of managing 50,000 to over 200,000 samples at -80°C with AI-driven automation, and the DWL368BPST ultra-low temperature freezer designed for Japan's space-constrained laboratories. Haier Biomedical is shifting from product exports to building integrated ecosystems through partnerships with local academic institutions like the Università degli Studi di Padova to support its global expansion strategy.PR NewswireHaier Biomedical erreicht in Euromonitors „Global Life Science Lab Equipment Report" einen doppelten ersten Platz und krönt damit seine dreistufige globale ExpansionHaier Biomedical (SHA: 688139) was ranked by Euromonitor International as the number one Chinese brand globally in life science lab equipment sales and the number one in overseas business in the same category for 2025. The company achieved this through a three-phase international expansion spanning 160 countries via over 800 active dealer relationships, with an average annual growth rate exceeding 20 percent. Q1 2026 growth exceeded 50 percent in Germany, Australia, and Canada while exceeding 100 percent in Eastern Europe, South Asia, and Brazil.NewswireHaier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global ExpansionHaier Biomedical ranked No.1 in global life science lab equipment sales and No.1 in overseas sales in Euromonitor's 2025 report. The dual ranking caps a three-phase expansion with over 20% CAGR, and Q1 2026 revenue in Germany, Australia, and Canada grew over 50%.PR NewswireHaier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global ExpansionHaier Biomedical ranked No. 1 in global life science lab equipment sales and overseas sales in Euromonitor's 2025 report. The company's three-phase expansion has delivered over 20% CAGR, with Q1 2026 revenue growth exceeding 50% in Germany, Australia, and Canada. It plans to deepen localization and expand its product range.PR NewswireHaier Biomedical publie son rapport sur le développement durable 2025 : pour la mise en place d'une plateforme technologique, industrielle et de responsabilité socialeHaier Biomedical (688139.SH), a global leader in life sciences and medical solutions based in Qingdao, China, published its 2025 sustainability report on May 21, 2026, outlining measurable progress across environmental, social, and governance dimensions through its LIFE framework aligned with the UN's 17 Sustainable Development Goals. The report highlights that R&D staff comprise 28.56% of the workforce with a total R&D investment of 323 million yuan ($47.25 million), and documents AI+ product innovations including a security cabinet achieving 99% recognition accuracy and a cytotoxic drug dispensing robot with 3D-AI vision. The company also disclosed $205,697.8 in charitable donations and partnerships with international organizations including GAVI, while committing to continued digital, global, and platform-oriented transformation.PR Newswire APACHaier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social ResponsibilityHaier Biomedical released its 2025 sustainability report, detailing progress in environmental, social, and governance under its LIFE framework. The company invested 323 million yuan in R&D, with new invention patents growing 50% year-on-year and AI products like a safety cabinet achieving 99% recognition accuracy. It plans to continue digital, global, and platform-driven transformation.PR NewswireHaier Biomedical est à l'origine d'un essor mondial de l'infrastructure des sciences de la vie : les activités internationales atteignent un niveau record, représentant 36 % du chiffre d'affaires annuHaier Biomedical published its 2025 annual report showing annual revenue of 2.33 billion yuan ($340.77 million), with international revenue rising 17.9% year-over-year to 840 million yuan, reaching a record 36% of total revenue. The company achieved double-digit growth across all international business sectors, including 26.0% growth in Asia-Pacific and 16.0% in Europe. AI-powered applications contributed 15% of total revenue, up 2.5 percentage points from 2024, as the company unveiled strategic goals targeting over 50% international revenue share, 40% contribution from acquisitions, and 30% AI-related revenue by 2028.PR NewswireHaier Biomedical stimuleert wereldwijde vooruitgang in de infrastructuur voor de biowetenschappen: Internationaal bedrijf bereikt recordhoogte met 36% van de jaarlijkse omzet in 2025Haier Biomedical published its 2025 annual report showing full-year revenue of 2.33 billion yuan ($340.77 million), representing 17.9% year-over-year growth, with international revenue reaching 840 million yuan (36% of total, a record high). The company achieved double-digit growth across all international regions including 26.0% in Asia-Pacific and 16.0% in Europe, while new business segments contributed 48.5% of total revenue and AI applications accounted for 15% of revenue. Haier Biomedical also disclosed strategic targets for the next three years aiming for over 50% international revenue share, more than 40% of future revenue from acquisitions, and over 30% of revenue from AI-related activities.